Wiley Online Library - 27 Nov 2022
Tenascin C is a valuable marker for melanoma progression independent of mutational status and MAPK inhibitor therapy ...
Nature - 05 Jul 2022
Characterization of IG-MYC -breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia ...